← Back to Bills
HR 7856118th CongressFailed / ExpiredHouse

PREVENT DIABETES Act

Policy Area: Health
View on Congress.gov
Origin Chamber
House
Last Updated
May 27, 2025
Latest Action Date
Dec 17, 2024

Latest Action

Referred to the Subcommittee on Health.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The PREVENT DIABETES Act (H.R. 7856) is a health-related bill introduced in the 118th Congress aimed at addressing diabetes prevention. The bill was referred to the Subcommittee on Health but did not advance further and ultimately failed or expired. Specific details about the bill's provisions, funding, or implementation mechanisms are not available in the provided source data.

Bottom Line

H.R. 7856, the PREVENT DIABETES Act, was introduced to focus on diabetes prevention but did not progress beyond subcommittee referral and expired without enactment.

Policy Risk Level
🟡 Medium
Neutral Risk Assessment
Key Points
  • The bill is focused on the health policy area, specifically diabetes prevention.
  • It was introduced in the House of Representatives during the 118th Congress.
  • The latest recorded action was referral to the Subcommittee on Health on December 17, 2024.
  • The bill ultimately failed or expired without further legislative action.
  • No official summary or full text is available to provide detailed content analysis.
Who Benefits?

['Individuals at risk of diabetes who may benefit from prevention programs if implemented.', 'Health agencies and organizations involved in diabetes prevention efforts.', 'Healthcare providers focusing on chronic disease prevention.']

Potential Concerns

['Lack of available full text and official summary limits understanding of implementation and funding details.', 'Uncertainty about the scope of authority and oversight mechanisms due to missing legislative text.', 'Potential cost implications and resource allocation are unknown without detailed provisions.']

Political Context

The bill was introduced in the House during the 118th Congress and referred to the Subcommittee on Health but did not advance further. The failure or expiration indicates it did not receive sufficient legislative support or priority to move forward during the session.

Hidden Impact Review

Hidden impact flags detected: 1

GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

1 Detected
Detected Flags
Indirect Effects

['If enacted, the bill could have led to increased funding or programs for diabetes prevention, potentially reducing long-term healthcare costs related to diabetes complications.', 'Failure to pass may delay or limit coordinated federal efforts to address diabetes prevention.']

GovScope Watchdog Notes

The absence of an official summary and full bill text is a significant transparency issue, hindering comprehensive analysis and public understanding. This limits the ability to assess the bill's potential impact, funding mechanisms, and oversight provisions. Future legislative proposals would benefit from complete documentation to facilitate informed debate and accountability.

Passage Likelihood: LowConfidence: 60%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready